F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
-
The committee endorsed broader use of the peptides in lightly regulated
compounding pharmacies that have grown into a multibillion-dollar business.
45 minutes ago



1 comment:
Plosser, a former dean of the Simon School of Business at Rochester University, was more circumspect.
"It could be very bad. At some level we don't really know what the consequences could be. It could be very serious. It could be less serious. Do we really want to run that experiment?"
Post a Comment